Postdoctoral Scientist – Leukaemia Biology Group

The University of Manchester

  • Salary in the range of £30,000 - £39,800 (dependent upon qualifications and experience)
  • Job Ref: MI/17/45
  • Duration of position: 3 years

A 3 year position is available in the laboratory of Professor Tim Somervaille to investigate novel therapeutic targets in the therapy of haematological malignancies. Building on our recent success you will focus on the identification and evaluation of epigenetic regulators that are required for primary human leukaemia cells but which are not required for normal human haematopoietic stem and progenitor cells. You will take on and develop the laboratory’s genome-wide CRISPR screening work, to identify candidate therapeutic targets for further evaluation and potential drug development.

The successful applicant should have a PhD in Biomedical Sciences. A background in biochemistry, chromatin, epigenetics and/or leukaemia is desirable but not required.

Informal enquiries should be directed via email to

The Cancer Research UK Manchester Institute (, an Institute of The University of Manchester (, is a world-leading centre for excellence in cancer research.  The Institute is core funded by Cancer Research UK (, the largest independent cancer research organisation in the world. We are currently situated at the internationally-renowned life sciences campus at Alderley Park in Cheshire England and the Manchester Cancer Research Centre (MCRC) in South Manchester.

We are partnered with The Christie NHS Foundation Trust (adjacent to the CRUK MI Paterson Building) in South Manchester (, one of the largest cancer treatment centres in Europe.  These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.

Our aim is to understand the fundamental basis of cancer and apply that knowledge to developing new treatment strategies for cancer patients.  Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to drug discovery, translational research and clinical trials.

The Institute has outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, bioinformatics, histology and mass-spectrometry. 

To apply for this position please visit our website:

Closing date: 13th September 2017.

Share this job
  Share by Email   Print this job   More sharing options
We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role:


Northern England